Brief: Tevogen Bio Announces Publication Of Positive Phase I Clinical Trial Results For TVGN 489 In Blood Advances

June 25 (Reuters) - Tevogen Bio Holdings Inc  TVGN.O :
    * TEVOGEN BIO ANNOUNCES PUBLICATION OF POSITIVE PHASE I
CLINICAL
TRIAL RESULTS FOR TVGN 489 IN BLOOD ADVANCES
    * TEVOGEN BIO HOLDINGS: TVGN 489 WAS WELL-TOLERATED AT ALL
FOUR
DOSES TESTED

Source text for Eikon:  ID:nGNX2KFg6V 
Further company coverage:  TVGN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Tevogen

See all news